ARTICLE AD BOX
Researchers in Brazil are advancing a promising form of cancer immunotherapy by making natural killer (NK) cells more powerful and precise. In a recent study, scientists at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) used the NK-92 cell line to test new designs of chimeric antigen receptors (CARs). These engineered receptors included specific costimulatory components, such as 2B4 and DAP12, that help activate the cells. The findings showed that these...

1 hour ago
5






English (US) ·